SCHEMBL16811853

SCHEMBL16811853

Cc1c(C(=O)NC2CCN(Cc3ccc(N4CCC(NC(=O)OC(C)(C)C)CC4)nc3)CC2)cccc1-c1ccncc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMO Q99835 1/20 0.53
▸ AKT1 P31749 1/20 0.46
▸ CKS1B P61024 1/20 0.45
▸ SKP1 P63208 1/20 0.45
▸ SKP2 Q13309 1/20 0.45
▸ CD274 Q9NZQ7 1/20 0.42
▸ DRD4 P21917 3/20 0.41
▸ POLB P06746 1/20 0.41
▸ RET P07949 1/20 0.41
▸ SLC6A5 Q9Y345 1/20 0.40
▸ SSTR5 P35346 1/20 0.40
▸ CCR3 P51677 1/20 0.40
▸ MCHR1 Q99705 1/20 0.40
▸ NSD2 O96028 1/20 0.40
▸ DRD3 P35462 1/20 0.40
▸ PARP1 P09874 1/20 0.39
▸ PARP2 Q9UGN5 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ SYK P43405 1/20 0.39
▸ SLC6A12 P48065 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16811840 0.93 SMO (0.62) SMOAKT1CKS1BSKP1SKP2
SCHEMBL18286504 0.93 SMO (0.50) SMOAKT1CKS1BSKP1SKP2
SCHEMBL16811809 0.92 SMO (0.52) SMOAKT1CKS1BSKP1SKP2
SCHEMBL16811842 0.92 SMO (0.52) SMOAKT1CKS1BSKP1SKP2
SCHEMBL16811792 0.92 SMO (0.52) SMOAKT1CKS1BSKP1SKP2
SCHEMBL18286598 0.89 SMO (0.51) SMOAKT1CKS1BSKP1SKP2
SCHEMBL16811811 0.89 SMO (0.57) SMOCD274DRD4POLBCCR3
SCHEMBL16811854 0.89 SMO (0.51) SMOAKT1CKS1BSKP1SKP2
SCHEMBL16811843 0.88 SMO (0.62) SMOCKS1BSKP1SKP2CD274
SCHEMBL16812725 0.87 SMO (0.46) SMOAKT1CKS1BSKP1SKP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9512106-B2 Smoothened modulators and methods of use thereof DUKE UNIVERSITY (US) 2016-12-06 — — US disclosed
US-9512106-B2 Smoothened modulators and methods of use thereof DUKE UNIVERSITY (US) 2016-12-06 — — US disclosed
US-20150166509-A1 SMOOTHENED MODULATORS AND METHODS OF USE THEREOF UNIV DUKE (US) 2015-06-18 — — US disclosed
US-20150166509-A1 SMOOTHENED MODULATORS AND METHODS OF USE THEREOF UNIV DUKE (US) 2015-06-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150166509-A1 SMOOTHENED MODULATORS AND METHODS OF USE THEREOF SMO, SHH, GLI1 SMO 1/4885AKT1 137/4885CKS1B 207/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback